pocketful logo light
pocketful logo light
Artemis Medicare Services Ltd logo

Artemis Medicare Services Ltd

NSE: ARTEMISMED BSE: 542919

₹274.95

(1.55%)

Thu, 30 Jul 2026, 11:24 am

Artemis Medicare Services Price to Sales Ratio (P/S)

Particulars201320142015201620172018201920202021202220232024
Price to earnings ratio000024.6919.649.2345.3220.0624.4448.1251.77
Price to book ratio00002.381.370.580.921.692.265.154.51
Price to sales ratio00001.290.750.330.721.151.282.694.57
Price to cash flow ratio00008.4712.243.9716.1112.378.3727.8231.81
Enterprise value0000726Cr504Cr281Cr411Cr813Cr1183Cr2630Cr4178Cr
Enterprise value to EBITDA ratio000011.998.585.0411.4311.9712.3519.5626.93
Debt to equity ratio0000.380.330.390.360.460.560.710.710.35
Return on equity %0-11.1384.6421.979.937.236.522.059.3610.1211.5412.85

Artemis Medicare Services Ltd Price to Sales Ratio

The Artemis Medicare Services Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Artemis Medicare Services Ltd's valuation, profitability, and overall financial performance. Tracking the Artemis Medicare Services Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Artemis Medicare Services Ltd (NSE: ARTEMISMED, BSE: 542919) is currently trading at ₹274.95, with a market capitalization of ₹4269.52Cr. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Artemis Medicare Services Ltd Price to Sales Ratio is essential for fundamental analysis.

Artemis Medicare Services Ltd Price to Sales Ratio Current Value

The current Artemis Medicare Services Ltd Price to Sales Ratio stands at 4.57.

The latest Artemis Medicare Services Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Artemis Medicare Services Ltd Price to Sales Ratio Historical Trend

The Artemis Medicare Services Ltd Price to Sales Ratio has shown the following historical trend:

  • 2024: 4.57
  • 2023: 2.69
  • 2022: 1.28
  • 2021: 1.15
  • 2020: 0.72

The recent rise in Artemis Medicare Services Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.

What Artemis Medicare Services Ltd Price to Sales Ratio Indicates for Investors

The Artemis Medicare Services Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Artemis Medicare Services Ltd Price to Sales Ratio Analysis Summary

The Artemis Medicare Services Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Artemis Medicare Services Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Artemis Medicare Services Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account

Enter your phone number